Using microarray analysis of gene expression in pretreatment biopsies of gastric cancer, Nakagawa et al. identified a functional gene signature consisting of 29 genes that are predictive of response to DCS therapy [46], among which JMJD2A was involved in gastric cancer chemosensitivity. Here, KDM4A is linked to gastric cancer.